Zymergen $125 Million Settlement, Check If You Qualify — Wang v. Zymergen Inc., No. 5:21-cv-06028-PCP

October 11, 2026. That’s your deadline to claim money from the Zymergen securities settlement, and it’s closer than it looks once you factor in digging up old brokerage records. Zymergen’s IPO underwriters, executives, and venture backers are paying $125 million to settle claims over the company’s collapsed 2021 stock offering. Filing takes about 15 minutes.

Zymergen Securities Settlement — Key Facts (Updated)

Field	Detail
Settlement Amount	$125,000,000
Claim Deadline	October 11, 2026
Who Qualifies	Investors who purchased or acquired Zymergen common stock traceable to the April 2021 IPO Registration Statement between April 21 and August 3, 2021
Estimated Payout	Average ~$6.21 per share before deductions; up to $22.75 per share under the Recognized Loss formula
Proof Required	Yes — broker confirmations or account statements
Settlement Status	Preliminarily approved June 22, 2026; final approval hearing October 13, 2026
Court & Case Number	U.S. District Court, N.D. California (San Jose), No. 5:21-cv-06028-PCP
Law Alleged	Securities Act of 1933, Sections 11 and 15
Administrator	Verita Global
Official Claim Site	www.ZymergenSecuritiesLitigation.com
Last Updated	July 28, 2026

Who Is Zymergen and Why Are They Being Sued Over the IPO?

Zymergen built its pitch around Hyaline, a synthetic-biology material it promised would open a $1.2 trillion market — a story good enough to justify a $31-a-share IPO in April 2021. Zymergen itself isn’t the one paying this settlement, though. The company went bankrupt in 2023 and its insurance is already exhausted, so the money comes from the IPO’s underwriters, its executives, and its largest venture backers instead — names like Goldman Sachs, JPMorgan, SoftBank, and True Ventures.

What Did Zymergen’s Registration Statement Leave Out?

The core claim here is a Section 11 claim under the Securities Act — meaning investors say the IPO paperwork itself contained false or misleading statements, full stop, regardless of intent. Zymergen’s registration statement talked up Hyaline’s readiness and market size, but the reality behind the scenes was different.

The truth came out fast. On August 3, 2021, after the market closed, Zymergen admitted that key target customers had encountered technical issues implementing Hyaline into their manufacturing processes, and that its addressable market was smaller than advertised. The stock closed at $8.25 the next day — a 73% drop from the $31 IPO price. That one disclosure is the entire case in miniature: a company tells investors one story at the IPO, then a very different one four months later.

Getting here took almost five years, including a fight over whether Zymergen’s venture investors — SoftBank, DCVC, and True Ventures — counted as “control persons” liable for the company’s statements, a question that went all the way to the Ninth Circuit before settlement talks took over. That control-person theory shows up in other IPO cases too; our coverage of the Expensify IPO settlement walks through a similar dispute over who’s actually on the hook when a registration statement goes wrong.

Five years of litigation, and it still comes down to one bad afternoon in August 2021.

Related article: Taylor Farms & Taco Bell Cyclospora Lawsuit, Were You Affected? — Null v. Taylor Fresh Foods, Inc., et al., No. 5:26-cv-07629

Who Qualifies for the Zymergen Securities Settlement?

Here’s exactly how to know if this settlement includes you.

• Investors who purchased or acquired Zymergen common stock traceable to the April 2021 Registration Statement between April 21 and August 3, 2021
• Anyone who held those shares through the close of trading on August 4, 2021, when the stock collapsed
• Investors who sold their Zymergen shares at a loss before the truth came out

You won’t qualify if you only bought Zymergen stock on or after August 4, 2021 — the plan values those purchases at zero — and option contracts on Zymergen stock aren’t eligible at all.

Zymergen Investors Outside California — Are You Still Covered?

This is a federal securities case, so it’s nationwide. It doesn’t matter what state you live in or which brokerage you used — what matters is whether your shares trace back to the April 2021 Registration Statement.

If your Zymergen shares are still sitting in an old brokerage statement somewhere, that statement is exactly what you’ll need to file.

Not sure if you qualify for the Zymergen settlement? A free consultation with a securities fraud attorney can help before the October 11, 2026 deadline.

How Much Can Zymergen Securities Settlement Class Members Get? Up to $22.75 Per Share

The estimated average payout is about $6.21 per share before deductions, though your actual “Recognized Loss Amount” depends on exactly when you bought and sold, using a first-in-first-out calculation. More filers means smaller individual checks, since the $125 million fund gets divided pro rata across everyone with a valid claim.

Payment won’t go out until after the October 13, 2026 hearing, and only once any appeals are resolved — that could take a while. Payments over $600 may appear on a 1099; check with a tax professional. No one will get “up to $22.75 a share” — actual amounts vary widely based on your specific trades.

Zymergen Payout With Proof of Purchase and Sale

What Pro-Rata Means for Your Zymergen Check

How to File Your Zymergen Settlement Claim — Step by Step

1. Go to the official claim site, www.ZymergenSecuritiesLitigation.com
2. Enter your name, contact information, and Social Security or Tax ID (last 4 digits)
3. List every Zymergen purchase, acquisition, and sale between April 21 and August 4, 2021, in chronological order
4. Attach broker confirmations or account statements — missing documentation can delay or sink your claim
5. Sign the certification page and submit online, or mail to Zymergen Securities Litigation, Claims Administrator, c/o Verita Global, P.O. Box 301135, Los Angeles, CA 90030-1135
6. Save your confirmation and watch email — the administrator will reach out if anything’s missing

Takes about 15 minutes if your records are on hand. You have until October 11, 2026.

Should Zymergen Class Members Object Before September 22, 2026?

There’s no new opt-out window here — the class was certified back in 2023, and that opt-out period already closed with no one excluding themselves. What’s open right now is only the right to object.

How to Object to the Zymergen Settlement

You stay in the class either way. To object, write to the Clerk of the Court, U.S. District Court for the Northern District of California, Robert F. Peckham Federal Building, 280 South 1st Street, Room 2112, San Jose, CA 95113, including your Zymergen trade details and the specific reasons for your objection, postmarked by September 22, 2026.

Talk to a class action lawsuit attorney before September 22, 2026 if you’re considering objecting.

Zymergen Securities Settlement — Key Dates, 2026

Milestone	Date
Stipulation of Settlement Executed	March 23, 2026
Preliminary Approval Granted	June 22, 2026
Objection Deadline	September 22, 2026
Claim Filing Deadline	October 11, 2026
Final Approval Hearing	October 13, 2026
Expected Payment Date	UNVERIFIED — pending final approval and resolution of any appeals

Zymergen $125 Million Settlement — Frequently Asked Questions, No. 5:21-cv-06028-PCP

Do I need a lawyer to file a Zymergen settlement claim? 

No. You can file the Proof of Claim yourself at www.ZymergenSecuritiesLitigation.com — a lawyer is optional.

Is the Zymergen $125 million settlement legitimate?

 Yes. It’s a court-supervised settlement in Wang v. Zymergen Inc., No. 5:21-cv-06028-PCP, preliminarily approved by the Northern District of California on June 22, 2026.

When will Zymergen settlement payments be sent?

 Not before the October 13, 2026 final approval hearing, and only after any appeals are resolved — there’s no confirmed payment date yet.

What if I missed the Zymergen claim deadline?

 Claims postmarked or submitted after October 11, 2026 risk rejection, though the Claims Administrator has discretion in some cases. File as early as possible instead of waiting.

Will my Zymergen settlement payment go on a 1099?

 Payments over $600 may be reported. Check with a tax professional about your specific situation.

Does Zymergen itself have to pay anything in this settlement?

 No. Zymergen went bankrupt in 2023 and its insurance is exhausted, so it’s excluded from the settlement. The underwriters, individual defendants, and venture investors are paying instead.

How much could I get if I bought Zymergen stock at the IPO and never sold? 

Your Recognized Loss Amount would be based on the $31 IPO price minus $8.25 (the August 4, 2021 closing price), capped at $22.75 per share — though your actual payout depends on how many other valid claims are filed.

What if I sold my Zymergen shares before the stock crashed on August 4, 2021? 

You may still have a claim, but it’s calculated differently — using your actual sale price rather than the post-crash value. The claim form walks through both scenarios.

Sources Used in This Zymergen Article

• Notice of Proposed Settlement of Class Action, Wang v. Zymergen Inc., et al., No. 5:21-cv-06028-PCP (N.D. Cal.): https://www.zymergensecuritieslitigation.com/media/7134595/v7_zym2_notice_070726_final.pdf
• Proof of Claim and Release Form, Zymergen Securities Litigation: https://www.zymergensecuritieslitigation.com/media/7134347/v5_zym2_poc_070626_final.pdf
• Official Settlement Website / Claims Portal: https://veritaconnect.com/ZymergenSecuritiesLitigation/

Researched and written by Israr, legal content researcher and founder of AllAboutLawyer.com. All facts verified against the official Notice of Proposed Settlement and Proof of Claim form on July 28, 2026. Last Updated: July 28, 2026.

This article is for informational purposes only and does not constitute legal advice. Laws vary by state and individual circumstances differ. For advice about your specific situation, consult a qualified attorney.